Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2830-2020Class II

Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) -

Pharmaceutical Innovations, Inc. / initiated 2020-08-13 / Terminated

Pharmaceutical Innovations, Inc. began a recall of Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) - Product Usage: A gel pad for use on woman s areola during... on . FDA classified it as Class II and gives the reason as "The firm registered the product as a Class I device, but has since been informed by FDA that the device is not Class I and requires a 510(k) submission". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2830-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Pharmaceutical Innovations, Inc.
Product
Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) - Product Usage: A gel pad for use on woman s areola during an ultrasound examination. Its primary purpose is for patient comfort over the loose gel and helps with nipple location during the scan, making the areola location easier to identify.
Product code
MUI Media, Coupling, Ultrasound
Reason for recall
The firm registered the product as a Class I device, but has since been informed by FDA that the device is not Class I and requires a 510(k) submission.
FDA root cause
No Marketing Application
Action
On 8/13/2020, the firm distributed Urgent Medical Device Recall letters to its distributor, with instructions to notify all affected customers who received the product. Customers were informed that the product had been misclassified by the firm and required a 510(k) submission to FDA. Customers were instructed to identify and quarantine the products, and to cease use and sales of the product. Customers are to complete the included response form and return it to the firm. The firm will issue a Return Material Authorization for the return of the product. No option will be given to destroy product in the field. Customers should notify all users within their facility as well as any downstream accounts if the product has been further distributed/ transferred.
Quantity in commerce
tbd
Distribution
US Nationwide distribution including in the state of Nevada.
Product codes and lots
Lots  021805-02 030805-02 050405-02 051106-02 052406-02 101006-02 101806-02 103406-02 052708-02 053308-02 060308-02 111208-02 111908-02 112108-02 050309-02 050809-02 101009-02 101309-02 061310-02 061710-02 061910-02 021411-02 021911-02 030211-02 030711-02 070711-02 113211-02 113311-02 011312-02 022112-02 030412-02 030812-02 061712-02 061912-02 070512-02 120612-02 011013-02 011313-02 021413-02 030313-02 051313-02 052713-02 060113-02 120613-02 011414-02 021314-02 022614-02 030614-02 060914-02 061314-02 062014-02 070714-02 100314-02 101614-02 110914-02 120314-02 020115-02 030115-02 060615-02 061315-02 070515-02 070815-02 100315-02 100615-02 110315-02 110715-02 120316-02 010416-02 011316-02 020216-02 021016-02 030516-02 052016-02 060316-02 091416-02 092316-02 100616-02 101516-02 102116-02 020517-02 021617-02 030817-02 031517-02 032417-02 040717-02 041017-02 050617-02 060317-02 071217-02 071917-02 080417-02 081717-02 091017-02 091617-02 092317-02 100517-02 021018-02 031318-02 040418-02 040718-02 041118-02 041318-02 041818-02 051218-02 060718-02 020619-02 020919-02

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2830-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2830-2020Class IITerminatedVoluntary: Firm initiated